Literature DB >> 21039540

Benefits of cocrystallisation in pharmaceutical materials science: an update.

Tomislav Friščić1, William Jones.   

Abstract

OBJECTIVES: We provide a brief overview of recent applications of cocrystals for improving the physico-chemical and materials properties of active pharmaceutical ingredients, including solubility, humidity and thermal stability, dissolution rates and compressibility for tablet formation. KEY
FINDINGS: This overview illustrates the pharmaceutical applications of cocrystals, with a selection of recent examples and also attempts to foresee future developments by proposing several directions not yet explored in the area of pharmaceutical cocrystallisation.
SUMMARY: Reliable strategies for the synthesis and design of pharmaceutical cocrystals have now been established, and the potential of cocrystallisation for enhancing the solid-state properties of drugs is well recognised; the field is now moving towards the understanding of cocrystal structure-property relationships, for which systematic structural studies and computational approaches will play a key role.
© 2010 The Authors. JPP © 2010 Royal Pharmaceutical Society of Great Britain.

Mesh:

Substances:

Year:  2010        PMID: 21039540     DOI: 10.1111/j.2042-7158.2010.01133.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  11 in total

1.  Metal-organic frameworks: 3D frameworks from 3D printers.

Authors:  Ian D Williams
Journal:  Nat Chem       Date:  2014-11       Impact factor: 24.427

2.  Physicomechanical, stability, and pharmacokinetic evaluation of aceclofenac dimethyl urea cocrystals.

Authors:  Hafsa Afzal; Nasir Abbas; Amjad Hussain; Sumera Latif; Kanwal Fatima; Muhammad Sohail Arshad; Nadeem Irfan Bukhari
Journal:  AAPS PharmSciTech       Date:  2021-02-09       Impact factor: 3.246

3.  Crystal engineering rescues a solution organic synthesis in a cocrystallization that confirms the configuration of a molecular ladder.

Authors:  Manza B J Atkinson; S V Santhana Mariappan; Dejan-Krešimir Bučar; Jonas Baltrusaitis; Tomislav Friščić; Naif G Sinada; Leonard R MacGillivray
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

4.  Instability in theophylline and carbamazepine hydrate tablets: cocrystal formation due to release of lattice water.

Authors:  Kapildev K Arora; Seema Thakral; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2013-04-09       Impact factor: 4.200

Review 5.  Mechanochemistry: A Green Approach in the Preparation of Pharmaceutical Cocrystals.

Authors:  Mizraín Solares-Briones; Guadalupe Coyote-Dotor; José C Páez-Franco; Miriam R Zermeño-Ortega; Carmen Myriam de la O Contreras; Daniel Canseco-González; Alcives Avila-Sorrosa; David Morales-Morales; Juan M Germán-Acacio
Journal:  Pharmaceutics       Date:  2021-05-25       Impact factor: 6.321

6.  4-Carbamoylpyridin-1-ium 2,2,2-tri-chloro-acetate-isonicotinamide (1/1).

Authors:  Franc Perdih
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-08-31

7.  4-Carbamoylpyridin-1-ium 2,2,2-trichloro-acetate.

Authors:  Franc Perdih
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-08-23

8.  Structural studies of crystalline forms of triamterene with carboxylic acid, GRAS and API molecules.

Authors:  Abida Rehman; Amit Delori; David S Hughes; William Jones
Journal:  IUCrJ       Date:  2018-04-06       Impact factor: 4.769

9.  Co-Crystal Formation of Antibiotic Nitrofurantoin Drug and Melamine Co-Former Based on a Vibrational Spectroscopic Study.

Authors:  Ziming Zhang; Qiang Cai; Jiadan Xue; Jianyuan Qin; Jianjun Liu; Yong Du
Journal:  Pharmaceutics       Date:  2019-01-30       Impact factor: 6.321

10.  Mechanochemical Preparation of Active Pharmaceutical Ingredients Monitored by In Situ Raman Spectroscopy.

Authors:  Irena Sović; Stipe Lukin; Ernest Meštrović; Ivan Halasz; Andrea Porcheddu; Francesco Delogu; Pier Carlo Ricci; Fabien Caron; Thomas Perilli; Anita Dogan; Evelina Colacino
Journal:  ACS Omega       Date:  2020-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.